Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations

Zeta potential of porous silicon nanoparticles is highly dependent on the nature of the loaded peptide and the isotonic medium. Recently, highly promising results considering the use of porous silicon (PSi) nanoparticles as a controlled and targeted drug delivery system have been published. Drugs ar...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 431; no. 1-2; pp. 230 - 236
Main Authors Kaasalainen, Martti, Mäkilä, Ermei, Riikonen, Joakim, Kovalainen, Miia, Järvinen, Kristiina, Herzig, Karl-Heinz, Lehto, Vesa-Pekka, Salonen, Jarno
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.07.2012
Subjects
Online AccessGet full text
ISSN0378-5173
1873-3476
1873-3476
DOI10.1016/j.ijpharm.2012.04.059

Cover

Abstract Zeta potential of porous silicon nanoparticles is highly dependent on the nature of the loaded peptide and the isotonic medium. Recently, highly promising results considering the use of porous silicon (PSi) nanoparticles as a controlled and targeted drug delivery system have been published. Drugs are typically loaded into PSi nanoparticles by electrostatic interactions, and the drug-loaded nanoparticles are then administered parenterally in isotonic solutions. Zeta potential has an important role in drug adsorption and overall physical stability of nanosuspensions. In the present study, we used zeta potential measurements to study the impact of the formulation components to the nanosuspension stability. The impact of medium was studied by measuring isoelectric points (IEP) and zeta potentials in isotonic media. The role of drug adsorption was demonstrated with gastrointestinal peptides GLP-1(7-37) and PYY (3-36) and the selection of isotonic additive was demonstrated with peptide-loaded PSi nanoparticles. The results show the notable effect of isotonic solutions and peptide adsorption on zeta potential of PSi nanosuspensions. As a rule of thumb, the sugars (sucrose, dextrose and mannitol) seem to be good media for negatively charged peptide-loaded particles and weak acids (citric- and lactic acid) for positively charged particles. Nevertheless, perhaps the most important rule can be given for isotonic salt solutions which all are very poor media when the stability of nanosuspension is considered.
AbstractList Recently, highly promising results considering the use of porous silicon (PSi) nanoparticles as a controlled and targeted drug delivery system have been published. Drugs are typically loaded into PSi nanoparticles by electrostatic interactions, and the drug-loaded nanoparticles are then administered parenterally in isotonic solutions. Zeta potential has an important role in drug adsorption and overall physical stability of nanosuspensions. In the present study, we used zeta potential measurements to study the impact of the formulation components to the nanosuspension stability. The impact of medium was studied by measuring isoelectric points (IEP) and zeta potentials in isotonic media. The role of drug adsorption was demonstrated with gastrointestinal peptides GLP-1(7-37) and PYY (3-36) and the selection of isotonic additive was demonstrated with peptide-loaded PSi nanoparticles. The results show the notable effect of isotonic solutions and peptide adsorption on zeta potential of PSi nanosuspensions. As a rule of thumb, the sugars (sucrose, dextrose and mannitol) seem to be good media for negatively charged peptide-loaded particles and weak acids (citric- and lactic acid) for positively charged particles. Nevertheless, perhaps the most important rule can be given for isotonic salt solutions which all are very poor media when the stability of nanosuspension is considered.
Zeta potential of porous silicon nanoparticles is highly dependent on the nature of the loaded peptide and the isotonic medium. Recently, highly promising results considering the use of porous silicon (PSi) nanoparticles as a controlled and targeted drug delivery system have been published. Drugs are typically loaded into PSi nanoparticles by electrostatic interactions, and the drug-loaded nanoparticles are then administered parenterally in isotonic solutions. Zeta potential has an important role in drug adsorption and overall physical stability of nanosuspensions. In the present study, we used zeta potential measurements to study the impact of the formulation components to the nanosuspension stability. The impact of medium was studied by measuring isoelectric points (IEP) and zeta potentials in isotonic media. The role of drug adsorption was demonstrated with gastrointestinal peptides GLP-1(7-37) and PYY (3-36) and the selection of isotonic additive was demonstrated with peptide-loaded PSi nanoparticles. The results show the notable effect of isotonic solutions and peptide adsorption on zeta potential of PSi nanosuspensions. As a rule of thumb, the sugars (sucrose, dextrose and mannitol) seem to be good media for negatively charged peptide-loaded particles and weak acids (citric- and lactic acid) for positively charged particles. Nevertheless, perhaps the most important rule can be given for isotonic salt solutions which all are very poor media when the stability of nanosuspension is considered.
Recently, highly promising results considering the use of porous silicon (PSi) nanoparticles as a controlled and targeted drug delivery system have been published. Drugs are typically loaded into PSi nanoparticles by electrostatic interactions, and the drug-loaded nanoparticles are then administered parenterally in isotonic solutions. Zeta potential has an important role in drug adsorption and overall physical stability of nanosuspensions. In the present study, we used zeta potential measurements to study the impact of the formulation components to the nanosuspension stability. The impact of medium was studied by measuring isoelectric points (IEP) and zeta potentials in isotonic media. The role of drug adsorption was demonstrated with gastrointestinal peptides GLP-1(7-37) and PYY (3-36) and the selection of isotonic additive was demonstrated with peptide-loaded PSi nanoparticles. The results show the notable effect of isotonic solutions and peptide adsorption on zeta potential of PSi nanosuspensions. As a rule of thumb, the sugars (sucrose, dextrose and mannitol) seem to be good media for negatively charged peptide-loaded particles and weak acids (citric- and lactic acid) for positively charged particles. Nevertheless, perhaps the most important rule can be given for isotonic salt solutions which all are very poor media when the stability of nanosuspension is considered.Recently, highly promising results considering the use of porous silicon (PSi) nanoparticles as a controlled and targeted drug delivery system have been published. Drugs are typically loaded into PSi nanoparticles by electrostatic interactions, and the drug-loaded nanoparticles are then administered parenterally in isotonic solutions. Zeta potential has an important role in drug adsorption and overall physical stability of nanosuspensions. In the present study, we used zeta potential measurements to study the impact of the formulation components to the nanosuspension stability. The impact of medium was studied by measuring isoelectric points (IEP) and zeta potentials in isotonic media. The role of drug adsorption was demonstrated with gastrointestinal peptides GLP-1(7-37) and PYY (3-36) and the selection of isotonic additive was demonstrated with peptide-loaded PSi nanoparticles. The results show the notable effect of isotonic solutions and peptide adsorption on zeta potential of PSi nanosuspensions. As a rule of thumb, the sugars (sucrose, dextrose and mannitol) seem to be good media for negatively charged peptide-loaded particles and weak acids (citric- and lactic acid) for positively charged particles. Nevertheless, perhaps the most important rule can be given for isotonic salt solutions which all are very poor media when the stability of nanosuspension is considered.
Author Lehto, Vesa-Pekka
Mäkilä, Ermei
Riikonen, Joakim
Salonen, Jarno
Kaasalainen, Martti
Järvinen, Kristiina
Kovalainen, Miia
Herzig, Karl-Heinz
Author_xml – sequence: 1
  givenname: Martti
  surname: Kaasalainen
  fullname: Kaasalainen, Martti
  organization: Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
– sequence: 2
  givenname: Ermei
  surname: Mäkilä
  fullname: Mäkilä, Ermei
  organization: Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
– sequence: 3
  givenname: Joakim
  surname: Riikonen
  fullname: Riikonen, Joakim
  organization: Department of Physics, University of Eastern Finland, FI-70211 Kuopio, Finland
– sequence: 4
  givenname: Miia
  surname: Kovalainen
  fullname: Kovalainen, Miia
  organization: School of Pharmacy, Pharmaceutical Technology, University of Eastern Finland, FI-70211 Kuopio, Finland
– sequence: 5
  givenname: Kristiina
  surname: Järvinen
  fullname: Järvinen, Kristiina
  organization: School of Pharmacy, Pharmaceutical Technology, University of Eastern Finland, FI-70211 Kuopio, Finland
– sequence: 6
  givenname: Karl-Heinz
  surname: Herzig
  fullname: Herzig, Karl-Heinz
  organization: Institute of Biomedicine, Biocenter of Oulu, University of Oulu, FI-90014 Oulu, Finland
– sequence: 7
  givenname: Vesa-Pekka
  surname: Lehto
  fullname: Lehto, Vesa-Pekka
  organization: Department of Physics, University of Eastern Finland, FI-70211 Kuopio, Finland
– sequence: 8
  givenname: Jarno
  surname: Salonen
  fullname: Salonen, Jarno
  email: jarno.salonen@utu.fi
  organization: Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22569227$$D View this record in MEDLINE/PubMed
BookMark eNqFkk2LFDEQhoOsuB_6E9QcvcxYSTpJBw8iy_oBCx50zyGbrqwZejptkl5YL_51MzujBy8DgUDxvFVFnpyTkylNSMhLBmsGTL3drONm_uHyds2B8TV0a5DmCTljvRYr0Wl1Qs5A6H4lmRan5LyUDQAozsQzcsq5VIZzfUZ-X4WAvtIUaCyppil6WtK41JimQt000BnnGgekbigpz7s6becXVkfnVHGq0Y27-JxyWgotcYy-AZOb0uxyjX5EOuTljg44xnvMDzSkvF1G9zjiOXka3FjwxeG-IDcfr75ffl5df_305fLD9cp3UtaVBwMBXC8GE5RXQmsIJjDd8_7WuVbsPZecOYbQY-cNhw65FtLz4DWXQlyQN_u-c04_FyzVbmPxOI5uwra2ZUr3UjFtzHFUGGOgE5IdR4HJTilQ0NBXB3S53eJg5xy3Lj_YvyoaIPeAz6mUjOEfwmDXSNmNPSi3O-UWOtuUt9y7_3I-1sfHrdnF8Wj69T4dXLLuLsdib741QEKDOtOrRrzfE9j03EfMtviIk8ch5vZz7JDikRl_AD7w1bw
CitedBy_id crossref_primary_10_1016_j_ajps_2020_11_002
crossref_primary_10_1016_j_ejpb_2019_12_008
crossref_primary_10_1039_D2NH00130F
crossref_primary_10_1021_acs_biomac_3c00424
crossref_primary_10_1007_s12274_015_0715_0
crossref_primary_10_1016_j_apsusc_2019_144359
crossref_primary_10_1039_C6RA27102B
crossref_primary_10_1016_j_elstat_2017_10_005
crossref_primary_10_1186_s11671_017_1853_y
crossref_primary_10_1016_j_apsusc_2019_05_317
crossref_primary_10_3389_fchem_2018_00539
crossref_primary_10_3390_ijms241914983
crossref_primary_10_4028_www_scientific_net_AMM_618_431
crossref_primary_10_1016_j_cej_2019_123414
crossref_primary_10_1103_PhysRevLett_125_037801
crossref_primary_10_1002_elps_201200549
crossref_primary_10_1021_la5047047
crossref_primary_10_1016_j_jinorgbio_2024_112549
crossref_primary_10_1016_j_colsurfb_2015_04_066
crossref_primary_10_1016_j_jclepro_2024_140956
crossref_primary_10_1039_C8CP01906A
crossref_primary_10_1080_10717544_2022_2092238
crossref_primary_10_1002_elps_201500374
crossref_primary_10_3897_pharmacia_69_e86907
crossref_primary_10_3390_md17080438
crossref_primary_10_1016_j_biomaterials_2015_01_008
crossref_primary_10_1016_j_xphs_2016_02_018
crossref_primary_10_1039_C7RA06829H
crossref_primary_10_1016_j_colsurfb_2017_02_022
crossref_primary_10_1134_S000635091404023X
crossref_primary_10_1016_j_jconrel_2013_05_036
crossref_primary_10_1080_03639045_2020_1862171
crossref_primary_10_1021_acsabm_9b00230
crossref_primary_10_1021_mp500787b
crossref_primary_10_1021_acssuschemeng_2c03506
crossref_primary_10_3390_molecules22112020
crossref_primary_10_3139_113_110469
crossref_primary_10_2217_nnm_15_53
crossref_primary_10_1002_jsfa_7768
crossref_primary_10_1080_08982104_2020_1818779
crossref_primary_10_3390_pharmaceutics14010126
crossref_primary_10_1016_j_materresbull_2014_05_014
crossref_primary_10_1039_C7CP00728K
crossref_primary_10_1016_j_bioactmat_2020_01_006
crossref_primary_10_3390_md14050090
crossref_primary_10_1039_D1CS01022K
crossref_primary_10_3390_pharmaceutics11120666
crossref_primary_10_1007_s12035_016_0200_0
crossref_primary_10_1016_j_jddst_2022_103323
crossref_primary_10_1016_j_colsurfb_2015_09_022
crossref_primary_10_1021_acsbiomaterials_6b00550
crossref_primary_10_1016_j_eurpolymj_2018_09_033
crossref_primary_10_1016_j_foodhyd_2013_12_022
crossref_primary_10_4028_www_scientific_net_AMR_669_217
crossref_primary_10_1089_jop_2017_0057
crossref_primary_10_1016_j_ijpharm_2012_06_037
crossref_primary_10_3390_ma11071083
crossref_primary_10_3390_pharmaceutics11110606
crossref_primary_10_1016_j_ijpharm_2013_06_063
crossref_primary_10_1208_s12249_016_0493_3
crossref_primary_10_1016_j_biomaterials_2013_08_034
crossref_primary_10_1080_03639045_2017_1371741
crossref_primary_10_3390_ph16030349
crossref_primary_10_4236_msa_2022_131003
crossref_primary_10_1016_j_jddst_2019_05_029
crossref_primary_10_2147_IJN_S421617
Cites_doi 10.1021/mp100227m
10.1016/S0142-9612(01)00267-8
10.1021/cm071289n
10.1053/j.gastro.2007.03.048
10.1006/jcis.1994.1419
10.1016/j.apsusc.2003.10.028
10.1016/j.biomaterials.2009.01.019
10.1016/S1748-0132(07)70084-1
10.1016/0021-9797(88)90407-9
10.1016/j.jconrel.2009.03.017
10.1016/0307-4412(86)90176-7
10.1016/j.jcis.2006.12.075
10.1002/jps.20999
10.1002/elps.200700734
10.1021/ja0719780
10.1098/rspa.1931.0133
10.1021/la904820k
10.1016/j.regpep.2007.10.008
10.1038/nmat2398
10.1021/la102367z
10.1039/c0cs00227e
10.1016/j.biomaterials.2009.02.008
10.1016/j.biomaterials.2007.07.029
10.1021/la202252m
10.1021/mp2001654
10.1021/nn100816s
10.1126/science.1095833
10.1063/1.1678153
10.3109/09687688.2010.522117
10.1021/ja0645943
10.1007/s11095-011-0453-2
10.1021/cr60234a002
10.1016/j.ijpharm.2005.10.010
10.1016/j.biomaterials.2010.12.011
10.1016/j.jconrel.2005.08.017
10.1016/S0142-9612(02)00440-4
10.1002/adma.19950071215
10.1007/s11095-011-0611-6
10.1021/bi060359l
10.1002/mrc.880
10.1021/nn901657w
10.1021/la00064a016
10.1021/nn103077k
10.1155/2008/712514
10.1021/la062450w
10.1517/17425240903199143
ContentType Journal Article
Copyright 2012 Elsevier B.V.
Copyright © 2012 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2012 Elsevier B.V.
– notice: Copyright © 2012 Elsevier B.V. All rights reserved.
DBID FBQ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7QO
8FD
FR3
P64
7S9
L.6
DOI 10.1016/j.ijpharm.2012.04.059
DatabaseName AGRIS
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE

AGRICOLA

MEDLINE - Academic
Engineering Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3476
EndPage 236
ExternalDocumentID 22569227
10_1016_j_ijpharm_2012_04_059
US201500124986
S037851731200405X
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSP
SSZ
T5K
TEORI
~02
~G-
.GJ
29J
3O-
53G
AAQXK
ABPIF
ABPTK
ASPBG
AVWKF
AZFZN
FBQ
FEDTE
FGOYB
G-2
HMT
HVGLF
R2-
SEW
SPT
WUQ
ZXP
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
ACLOT
~HD
7QO
8FD
FR3
P64
7S9
L.6
ID FETCH-LOGICAL-c455t-c090f0a83d9f6c63770f9f17828baad9f8c2521a1e08e4c9204e2735c2fc72533
IEDL.DBID AIKHN
ISSN 0378-5173
1873-3476
IngestDate Sun Sep 28 01:32:21 EDT 2025
Fri Sep 05 04:43:53 EDT 2025
Sat Sep 27 20:16:13 EDT 2025
Mon Jul 21 05:54:36 EDT 2025
Tue Jul 01 00:28:51 EDT 2025
Thu Apr 24 23:01:31 EDT 2025
Wed Dec 27 19:17:04 EST 2023
Fri Feb 23 02:20:34 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1-2
Keywords Nanoparticles
Gastrointestinal peptide
Isotonic formulation
Zeta potential
Porous silicon
Parenteral peptide delivery
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2012 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c455t-c090f0a83d9f6c63770f9f17828baad9f8c2521a1e08e4c9204e2735c2fc72533
Notes http://dx.doi.org/10.1016/j.ijpharm.2012.04.059
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 22569227
PQID 1015466060
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1678561799
proquest_miscellaneous_1399904351
proquest_miscellaneous_1015466060
pubmed_primary_22569227
crossref_primary_10_1016_j_ijpharm_2012_04_059
crossref_citationtrail_10_1016_j_ijpharm_2012_04_059
fao_agris_US201500124986
elsevier_sciencedirect_doi_10_1016_j_ijpharm_2012_04_059
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-07-15
PublicationDateYYYYMMDD 2012-07-15
PublicationDate_xml – month: 07
  year: 2012
  text: 2012-07-15
  day: 15
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle International journal of pharmaceutics
PublicationTitleAlternate Int J Pharm
PublicationYear 2012
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Slowing, Trewyn, Lin (bib0240) 2007; 129
Asati, Santra, Kaittanis, Perez (bib0015) 2010; 4
Rosenholm, Lindén (bib0195) 2007; 19
Cameselle, Ribeiro, Sillero (bib0045) 1986; 14
Salonen, Kaukonen, Hirvonen, Lehto (bib0215) 2008; 97
Gu, Biswas, Zhao, Tang (bib0070) 2011; 40
Wren, Bloom (bib0260) 2007; 132
Parks (bib0180) 1965; 65
Rosenholm, Czuryszkiewicz, Kleitz, Rosenholm, Lindén (bib0200) 2007; 23
Koppel (bib0115) 1972; 57
Kosmulski (bib0120) 2009
Slowing, Trewyn, Lin (bib0235) 2006; 128
Mäkilä, E., Kaasalainen, M., Héllsten, S., Louhi-Kultanen, M., Airaksinen A.J., Kukk, E., Salonen, J., Aminofunctionalization of thermally carbonized porous silicon with silane coupling chemistry, submitted for publication.
Tandon, Bhagavatula, Nelson, Kirby (bib0245) 2008; 29
De Rosa, Chiappini, Fan, Liu, Ferrari, Tasciotti (bib0190) 2011; 28
Jarvis, Barnes, Prestidge (bib0090) 2010; 26
Koopal, Hlady, Lyklema (bib0110) 1988; 121
Ohshima (bib0165) 1994; 168
Zhang, Kohler, Zhang (bib0265) 2002; 23
Bimbo, Sarparanta, Santos, Airaksinen, Mäkilä, Laaksonen, Peltonen, Lehto, Hirvonen, Salonen (bib0030) 2010; 4
Delgado, González-Caballero, Hunter, Koopal, Lyklema (bib0055) 2007; 309
Nieto, Colilla, Balas, Vallet-Regí (bib0155) 2010; 26
Allen, Cullis (bib0005) 2004; 303
Bimbo, Mäkilä, Laaksonen, Lehto, Salonen, Hirvonen, Santos (bib0025) 2011; 32
Nelson, Cox (bib0150) 2000
Jorgensen, Hostrup, Moeller, Grohganz (bib0095) 2009; 6
Bergman, Rosenholm, Öst, Duchanoy, Kankaanpää, Heino, Lindén (bib0020) 2008
Budavari, O’Neil, Smith, Heckelman (bib0035) 2001
Serda, Gu, Bhavane, Liu, Chiappini, Decuzzi, Ferrari (bib0230) 2009; 30
Lide (bib0130) 2008
Karhunen, Juvonen, Huotari, Purhonen, Herzig (bib0100) 2008; 149
Low, Voelcker, Canham, Williams (bib0135) 2009; 30
Wang, Coffer, Dorraj, Hartman, Armano, Canham (bib0250) 2010; 7
Salonen, Björkqvist, Laine, Niinistö (bib0210) 2004; 225
Morrison, Grabowski (bib0140) 1985; 1
Sarparanta, Mäkilä, Heikkilä, Salonen, Kukk, Lehto, Santos, Hirvonen, Airaksinen (bib0225) 2011; 8
Park, Gu, von Maltzahn, Ruoslahti, Bhatia, Sailor (bib0175) 2009; 8
Arruebo, Fernández-Pacheco, Ibarra, Santamaría (bib0010) 2007; 2
Canham (bib0040) 1995; 7
Huang, Mocherla, Heslinga, Charoenphol, Eniola-Adefeso (bib0080) 2010; 27
Florence, Attwood (bib0065) 2011
Ferstl, Strasser, Wittmann, Drechsler, Rischer, Engel, Goepferich (bib0060) 2011; 27
Nygaard, Nielbo, Schwartz, Poulsen (bib0160) 2006; 45
Hunter (bib0085) 2001
Rytkönen, J., Miettinen, R., Kaasalainen, M., Lehto, V.P., Salonen, J., Närvänen, A., Functionalization of mesoporous silicon nanoparticles for targeting and bioimaging purposes, submitted for publication.
Kilpeläinen, Riikonen, Vlasova, Huotari, Lehto, Salonen, Herzig, Järvinen (bib0105) 2009; 137
Wilhelm, Billotey, Roger, Pons, Bacri, Gazeau (bib0255) 2003; 24
Chang, Keller, Björn, Led (bib0050) 2001; 39
Salonen, Laitinen, Kaukonen, Tuura, Björkqvist, Heikkilä, Vähä-Heikkilä, Hirvonen, Lehto (bib0220) 2005; 108
Zhao, Sun, Zhang, Trewyn, Slowing, Lin (bib0270) 2011; 5
Owens, Peppas (bib0170) 2006; 307
Patil, Sandberg, Heckert, Self, Seal (bib0185) 2007; 28
Kovalainen, Mönkäre, Mäkilä, Salonen, Lehto, Herzig, Järvinen (bib0125) 2012; 29
Henry (bib0075) 1931; 133
Koopal (10.1016/j.ijpharm.2012.04.059_bib0110) 1988; 121
Bimbo (10.1016/j.ijpharm.2012.04.059_bib0030) 2010; 4
Koppel (10.1016/j.ijpharm.2012.04.059_bib0115) 1972; 57
Florence (10.1016/j.ijpharm.2012.04.059_bib0065) 2011
Lide (10.1016/j.ijpharm.2012.04.059_bib0130) 2008
Ohshima (10.1016/j.ijpharm.2012.04.059_bib0165) 1994; 168
Rosenholm (10.1016/j.ijpharm.2012.04.059_bib0200) 2007; 23
Kovalainen (10.1016/j.ijpharm.2012.04.059_bib0125) 2012; 29
Sarparanta (10.1016/j.ijpharm.2012.04.059_bib0225) 2011; 8
De Rosa (10.1016/j.ijpharm.2012.04.059_bib0190) 2011; 28
Serda (10.1016/j.ijpharm.2012.04.059_bib0230) 2009; 30
Gu (10.1016/j.ijpharm.2012.04.059_bib0070) 2011; 40
Kilpeläinen (10.1016/j.ijpharm.2012.04.059_bib0105) 2009; 137
Asati (10.1016/j.ijpharm.2012.04.059_bib0015) 2010; 4
Patil (10.1016/j.ijpharm.2012.04.059_bib0185) 2007; 28
Park (10.1016/j.ijpharm.2012.04.059_bib0175) 2009; 8
Rosenholm (10.1016/j.ijpharm.2012.04.059_bib0195) 2007; 19
Bimbo (10.1016/j.ijpharm.2012.04.059_bib0025) 2011; 32
10.1016/j.ijpharm.2012.04.059_bib0145
Allen (10.1016/j.ijpharm.2012.04.059_bib0005) 2004; 303
Jarvis (10.1016/j.ijpharm.2012.04.059_bib0090) 2010; 26
Jorgensen (10.1016/j.ijpharm.2012.04.059_bib0095) 2009; 6
Kosmulski (10.1016/j.ijpharm.2012.04.059_bib0120) 2009
Henry (10.1016/j.ijpharm.2012.04.059_bib0075) 1931; 133
Owens (10.1016/j.ijpharm.2012.04.059_bib0170) 2006; 307
Tandon (10.1016/j.ijpharm.2012.04.059_bib0245) 2008; 29
Delgado (10.1016/j.ijpharm.2012.04.059_bib0055) 2007; 309
Morrison (10.1016/j.ijpharm.2012.04.059_bib0140) 1985; 1
Salonen (10.1016/j.ijpharm.2012.04.059_bib0220) 2005; 108
Huang (10.1016/j.ijpharm.2012.04.059_bib0080) 2010; 27
Chang (10.1016/j.ijpharm.2012.04.059_bib0050) 2001; 39
Wilhelm (10.1016/j.ijpharm.2012.04.059_bib0255) 2003; 24
Canham (10.1016/j.ijpharm.2012.04.059_bib0040) 1995; 7
Hunter (10.1016/j.ijpharm.2012.04.059_bib0085) 2001
Salonen (10.1016/j.ijpharm.2012.04.059_bib0215) 2008; 97
Cameselle (10.1016/j.ijpharm.2012.04.059_bib0045) 1986; 14
Low (10.1016/j.ijpharm.2012.04.059_bib0135) 2009; 30
Ferstl (10.1016/j.ijpharm.2012.04.059_bib0060) 2011; 27
Nieto (10.1016/j.ijpharm.2012.04.059_bib0155) 2010; 26
Arruebo (10.1016/j.ijpharm.2012.04.059_bib0010) 2007; 2
Slowing (10.1016/j.ijpharm.2012.04.059_bib0240) 2007; 129
Salonen (10.1016/j.ijpharm.2012.04.059_bib0210) 2004; 225
Zhang (10.1016/j.ijpharm.2012.04.059_bib0265) 2002; 23
Wren (10.1016/j.ijpharm.2012.04.059_bib0260) 2007; 132
Nelson (10.1016/j.ijpharm.2012.04.059_bib0150) 2000
Nygaard (10.1016/j.ijpharm.2012.04.059_bib0160) 2006; 45
Slowing (10.1016/j.ijpharm.2012.04.059_bib0235) 2006; 128
Budavari (10.1016/j.ijpharm.2012.04.059_bib0035) 2001
Karhunen (10.1016/j.ijpharm.2012.04.059_bib0100) 2008; 149
Zhao (10.1016/j.ijpharm.2012.04.059_bib0270) 2011; 5
10.1016/j.ijpharm.2012.04.059_bib0205
Bergman (10.1016/j.ijpharm.2012.04.059_bib0020) 2008
Wang (10.1016/j.ijpharm.2012.04.059_bib0250) 2010; 7
Parks (10.1016/j.ijpharm.2012.04.059_bib0180) 1965; 65
References_xml – year: 2008
  ident: bib0130
  article-title: CRC Handbook of Chemistry and Physics
– volume: 4
  start-page: 3023
  year: 2010
  end-page: 3032
  ident: bib0030
  article-title: Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats
  publication-title: ACS Nano
– year: 2000
  ident: bib0150
  article-title: Lehninger Principles of Biochemistry
– volume: 7
  start-page: 2232
  year: 2010
  end-page: 2239
  ident: bib0250
  article-title: Sustained antibacterial activity from triclosan-loaded nanostructured mesoporous silicon
  publication-title: Mol. Pharm.
– volume: 168
  start-page: 269
  year: 1994
  end-page: 271
  ident: bib0165
  article-title: A simple expression for Henry's function for the retardation effect in electrophoresis of spherical colloidal particles
  publication-title: J. Colloid Interface Sci.
– volume: 28
  start-page: 4600
  year: 2007
  end-page: 4607
  ident: bib0185
  article-title: Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential
  publication-title: Biomaterials
– volume: 7
  start-page: 1033
  year: 1995
  end-page: 1037
  ident: bib0040
  article-title: Bioactive silicon structure fabrication through nanoetching techniques
  publication-title: Adv. Mater.
– start-page: 1
  year: 2008
  end-page: 9
  ident: bib0020
  article-title: On the complexity of electrostatic suspension stabilization of functionalized silica nanoparticles for biotargeting and imaging applications
  publication-title: J. Nanomater.
– volume: 27
  start-page: 312
  year: 2010
  end-page: 327
  ident: bib0080
  article-title: Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery
  publication-title: Mol. Membr. Biol.
– volume: 27
  start-page: 14450
  year: 2011
  end-page: 14459
  ident: bib0060
  article-title: Nanofibers resulting from cooperative electrostatic and hydrophobic interactions between peptides and polyelectrolytes of opposite charge
  publication-title: Langmuir
– volume: 303
  start-page: 1818
  year: 2004
  end-page: 1822
  ident: bib0005
  article-title: Drug delivery systems: entering the mainstream
  publication-title: Science
– volume: 19
  start-page: 5023
  year: 2007
  end-page: 5034
  ident: bib0195
  article-title: Wet-chemical analysis of surface concentration of accessible groups on different amino-functionalized mesoporous SBA-15 silicas
  publication-title: Chem. Mater.
– volume: 29
  start-page: 1092
  year: 2008
  end-page: 1101
  ident: bib0245
  article-title: Zeta potential and electroosmotic mobility in microfluidic devices fabricated from hydrophobic polymers: 1. The origins of charge
  publication-title: Electrophoresis
– volume: 39
  start-page: 477
  year: 2001
  end-page: 483
  ident: bib0050
  article-title: Structure and folding of glucagon-like peptide-1-(7-36)-amide in aqueous trifluoroethanol studied by NMR spectroscopy
  publication-title: Magn. Reson. Chem.
– volume: 225
  start-page: 389
  year: 2004
  end-page: 394
  ident: bib0210
  article-title: Stabilization of porous silicon surface by thermal decomposition of acetylene
  publication-title: Appl. Surf. Sci.
– volume: 30
  start-page: 2440
  year: 2009
  end-page: 2448
  ident: bib0230
  article-title: The association of silicon microparticles with endothelial cells in drug delivery to the vasculature
  publication-title: Biomaterials
– volume: 108
  start-page: 362
  year: 2005
  end-page: 374
  ident: bib0220
  article-title: Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs
  publication-title: J. Control. Release
– year: 2001
  ident: bib0085
  article-title: Foundations of Colloid Science
– volume: 128
  start-page: 14792
  year: 2006
  end-page: 14793
  ident: bib0235
  article-title: Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells
  publication-title: J. Am. Chem. Soc.
– volume: 129
  start-page: 8845
  year: 2007
  end-page: 8849
  ident: bib0240
  article-title: Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins
  publication-title: J. Am. Chem. Soc.
– volume: 40
  start-page: 3638
  year: 2011
  end-page: 3655
  ident: bib0070
  article-title: Tailoring nanocarriers for intracellular protein delivery
  publication-title: Chem. Soc. Rev.
– volume: 23
  start-page: 1553
  year: 2002
  end-page: 1561
  ident: bib0265
  article-title: Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake
  publication-title: Biomaterials
– volume: 149
  start-page: 70
  year: 2008
  end-page: 78
  ident: bib0100
  article-title: Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans
  publication-title: Regul. Pept.
– volume: 28
  start-page: 1520
  year: 2011
  end-page: 1530
  ident: bib0190
  article-title: Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system
  publication-title: Pharm. Res.
– volume: 57
  start-page: 4814
  year: 1972
  end-page: 4821
  ident: bib0115
  article-title: Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants
  publication-title: J. Chem. Phys.
– volume: 45
  start-page: 8350
  year: 2006
  end-page: 8357
  ident: bib0160
  article-title: The PP-fold solution structure of human polypeptide YY and human PYY3-36 as determined by NMR
  publication-title: Biochemistry-US
– volume: 8
  start-page: 1799
  year: 2011
  end-page: 1806
  ident: bib0225
  article-title: 18F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography
  publication-title: Mol. Pharm.
– volume: 6
  start-page: 1219
  year: 2009
  end-page: 1230
  ident: bib0095
  article-title: Recent trends in stabilising peptides and proteins in pharmaceutical formulation – considerations in the choice of excipients
  publication-title: Expert Opin. Drug Deliv.
– volume: 132
  start-page: 2116
  year: 2007
  end-page: 2130
  ident: bib0260
  article-title: Gut hormones and appetite control
  publication-title: Gastroenterology
– volume: 24
  start-page: 1001
  year: 2003
  end-page: 1011
  ident: bib0255
  article-title: Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating
  publication-title: Biomaterials
– volume: 97
  start-page: 632
  year: 2008
  end-page: 653
  ident: bib0215
  article-title: Mesoporous silicon in drug delivery applications
  publication-title: J. Pharm. Sci.
– volume: 4
  start-page: 5321
  year: 2010
  end-page: 5331
  ident: bib0015
  article-title: Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles
  publication-title: ACS Nano
– year: 2001
  ident: bib0035
  article-title: The Merck Index
– volume: 309
  start-page: 194
  year: 2007
  end-page: 224
  ident: bib0055
  article-title: Measurement and interpretation of electrokinetic phenomena
  publication-title: J. Colloid Interface Sci.
– volume: 1
  start-page: 496
  year: 1985
  end-page: 501
  ident: bib0140
  article-title: Improved techniques for particle size determination by quasi-elastic light scattering
  publication-title: Langmuir
– reference: Mäkilä, E., Kaasalainen, M., Héllsten, S., Louhi-Kultanen, M., Airaksinen A.J., Kukk, E., Salonen, J., Aminofunctionalization of thermally carbonized porous silicon with silane coupling chemistry, submitted for publication.
– volume: 2
  start-page: 22
  year: 2007
  end-page: 32
  ident: bib0010
  article-title: Magnetic nanoparticles for drug delivery
  publication-title: Nano Today
– volume: 26
  start-page: 5038
  year: 2010
  end-page: 5049
  ident: bib0155
  article-title: Surface electrochemistry of mesoporous silicas as a key factor in the design of tailored delivery devices
  publication-title: Langmuir
– volume: 137
  start-page: 166
  year: 2009
  end-page: 170
  ident: bib0105
  article-title: In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles
  publication-title: J. Control. Release
– volume: 14
  start-page: 131
  year: 1986
  end-page: 136
  ident: bib0045
  article-title: Derivation and use of a formula to calculate the net charge of acid–base compounds. Its application to amino acids, proteins and nucleotides
  publication-title: Biochem. Educ.
– year: 2009
  ident: bib0120
  article-title: Surface Charging and Points of Zero Charge, Surfactant Science Series 145
– volume: 32
  start-page: 2625
  year: 2011
  end-page: 2633
  ident: bib0025
  article-title: Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  publication-title: Biomaterials
– volume: 29
  start-page: 837
  year: 2012
  end-page: 846
  ident: bib0125
  article-title: Mesoporous silicon (PSi) for sustained peptide delivery: effect of PSi microparticle surface chemistry on peptide YY3-36 release
  publication-title: Pharm. Res.
– volume: 307
  start-page: 93
  year: 2006
  end-page: 102
  ident: bib0170
  article-title: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
  publication-title: Int. J. Pharm.
– volume: 5
  start-page: 1366
  year: 2011
  end-page: 1375
  ident: bib0270
  article-title: Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects
  publication-title: ACS Nano
– year: 2011
  ident: bib0065
  article-title: Physicochemical Principles of Pharmacy
– volume: 8
  start-page: 331
  year: 2009
  end-page: 336
  ident: bib0175
  article-title: Biodegradable luminescent porous silicon nanoparticles for in vivo applications
  publication-title: Nat. Mater.
– volume: 133
  start-page: 106
  year: 1931
  end-page: 129
  ident: bib0075
  article-title: The cataphoresis of suspended particles. Part I.–The equation of cataphoresis
  publication-title: Proc. R. Soc. London, A Math. Phys. Sci.
– volume: 26
  start-page: 14316
  year: 2010
  end-page: 14322
  ident: bib0090
  article-title: Thermal ocidation for controlling protein interactions with porous silicon
  publication-title: Langmuir
– volume: 65
  start-page: 177
  year: 1965
  end-page: 198
  ident: bib0180
  article-title: The isoelectric points of solid oxides, solid hydroxides, and aqueous hydroxo complex systems
  publication-title: Chem. Rev.
– reference: Rytkönen, J., Miettinen, R., Kaasalainen, M., Lehto, V.P., Salonen, J., Närvänen, A., Functionalization of mesoporous silicon nanoparticles for targeting and bioimaging purposes, submitted for publication.
– volume: 23
  start-page: 4315
  year: 2007
  end-page: 4323
  ident: bib0200
  article-title: On the nature of the Brønsted acidic groups on native and functionalized mesoporous siliceous SBA-15 as studied by benzylamine adsorption from solution
  publication-title: Langmuir
– volume: 121
  start-page: 49
  year: 1988
  end-page: 62
  ident: bib0110
  article-title: Electrophoretic study of polymer adsorption: dextran, polyethylene oxide and polyvinyl alcohol on silver iodide
  publication-title: J. Colloid Interface Sci.
– volume: 30
  start-page: 2873
  year: 2009
  end-page: 2880
  ident: bib0135
  article-title: The biocompatibility of porous silicon in tissues of the eye
  publication-title: Biomaterials
– volume: 7
  start-page: 2232
  year: 2010
  ident: 10.1016/j.ijpharm.2012.04.059_bib0250
  article-title: Sustained antibacterial activity from triclosan-loaded nanostructured mesoporous silicon
  publication-title: Mol. Pharm.
  doi: 10.1021/mp100227m
– ident: 10.1016/j.ijpharm.2012.04.059_bib0145
– volume: 23
  start-page: 1553
  year: 2002
  ident: 10.1016/j.ijpharm.2012.04.059_bib0265
  article-title: Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake
  publication-title: Biomaterials
  doi: 10.1016/S0142-9612(01)00267-8
– volume: 19
  start-page: 5023
  year: 2007
  ident: 10.1016/j.ijpharm.2012.04.059_bib0195
  article-title: Wet-chemical analysis of surface concentration of accessible groups on different amino-functionalized mesoporous SBA-15 silicas
  publication-title: Chem. Mater.
  doi: 10.1021/cm071289n
– volume: 132
  start-page: 2116
  year: 2007
  ident: 10.1016/j.ijpharm.2012.04.059_bib0260
  article-title: Gut hormones and appetite control
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.048
– volume: 168
  start-page: 269
  year: 1994
  ident: 10.1016/j.ijpharm.2012.04.059_bib0165
  article-title: A simple expression for Henry's function for the retardation effect in electrophoresis of spherical colloidal particles
  publication-title: J. Colloid Interface Sci.
  doi: 10.1006/jcis.1994.1419
– volume: 225
  start-page: 389
  year: 2004
  ident: 10.1016/j.ijpharm.2012.04.059_bib0210
  article-title: Stabilization of porous silicon surface by thermal decomposition of acetylene
  publication-title: Appl. Surf. Sci.
  doi: 10.1016/j.apsusc.2003.10.028
– volume: 30
  start-page: 2440
  year: 2009
  ident: 10.1016/j.ijpharm.2012.04.059_bib0230
  article-title: The association of silicon microparticles with endothelial cells in drug delivery to the vasculature
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.01.019
– volume: 2
  start-page: 22
  year: 2007
  ident: 10.1016/j.ijpharm.2012.04.059_bib0010
  article-title: Magnetic nanoparticles for drug delivery
  publication-title: Nano Today
  doi: 10.1016/S1748-0132(07)70084-1
– volume: 121
  start-page: 49
  year: 1988
  ident: 10.1016/j.ijpharm.2012.04.059_bib0110
  article-title: Electrophoretic study of polymer adsorption: dextran, polyethylene oxide and polyvinyl alcohol on silver iodide
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/0021-9797(88)90407-9
– volume: 137
  start-page: 166
  year: 2009
  ident: 10.1016/j.ijpharm.2012.04.059_bib0105
  article-title: In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2009.03.017
– volume: 14
  start-page: 131
  year: 1986
  ident: 10.1016/j.ijpharm.2012.04.059_bib0045
  article-title: Derivation and use of a formula to calculate the net charge of acid–base compounds. Its application to amino acids, proteins and nucleotides
  publication-title: Biochem. Educ.
  doi: 10.1016/0307-4412(86)90176-7
– volume: 309
  start-page: 194
  year: 2007
  ident: 10.1016/j.ijpharm.2012.04.059_bib0055
  article-title: Measurement and interpretation of electrokinetic phenomena
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/j.jcis.2006.12.075
– volume: 97
  start-page: 632
  year: 2008
  ident: 10.1016/j.ijpharm.2012.04.059_bib0215
  article-title: Mesoporous silicon in drug delivery applications
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.20999
– volume: 29
  start-page: 1092
  year: 2008
  ident: 10.1016/j.ijpharm.2012.04.059_bib0245
  article-title: Zeta potential and electroosmotic mobility in microfluidic devices fabricated from hydrophobic polymers: 1. The origins of charge
  publication-title: Electrophoresis
  doi: 10.1002/elps.200700734
– year: 2008
  ident: 10.1016/j.ijpharm.2012.04.059_bib0130
– ident: 10.1016/j.ijpharm.2012.04.059_bib0205
– volume: 129
  start-page: 8845
  year: 2007
  ident: 10.1016/j.ijpharm.2012.04.059_bib0240
  article-title: Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja0719780
– volume: 133
  start-page: 106
  year: 1931
  ident: 10.1016/j.ijpharm.2012.04.059_bib0075
  article-title: The cataphoresis of suspended particles. Part I.–The equation of cataphoresis
  publication-title: Proc. R. Soc. London, A Math. Phys. Sci.
  doi: 10.1098/rspa.1931.0133
– volume: 26
  start-page: 5038
  year: 2010
  ident: 10.1016/j.ijpharm.2012.04.059_bib0155
  article-title: Surface electrochemistry of mesoporous silicas as a key factor in the design of tailored delivery devices
  publication-title: Langmuir
  doi: 10.1021/la904820k
– volume: 149
  start-page: 70
  year: 2008
  ident: 10.1016/j.ijpharm.2012.04.059_bib0100
  article-title: Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans
  publication-title: Regul. Pept.
  doi: 10.1016/j.regpep.2007.10.008
– volume: 8
  start-page: 331
  year: 2009
  ident: 10.1016/j.ijpharm.2012.04.059_bib0175
  article-title: Biodegradable luminescent porous silicon nanoparticles for in vivo applications
  publication-title: Nat. Mater.
  doi: 10.1038/nmat2398
– year: 2009
  ident: 10.1016/j.ijpharm.2012.04.059_bib0120
– volume: 26
  start-page: 14316
  year: 2010
  ident: 10.1016/j.ijpharm.2012.04.059_bib0090
  article-title: Thermal ocidation for controlling protein interactions with porous silicon
  publication-title: Langmuir
  doi: 10.1021/la102367z
– volume: 40
  start-page: 3638
  year: 2011
  ident: 10.1016/j.ijpharm.2012.04.059_bib0070
  article-title: Tailoring nanocarriers for intracellular protein delivery
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/c0cs00227e
– year: 2011
  ident: 10.1016/j.ijpharm.2012.04.059_bib0065
– volume: 30
  start-page: 2873
  year: 2009
  ident: 10.1016/j.ijpharm.2012.04.059_bib0135
  article-title: The biocompatibility of porous silicon in tissues of the eye
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.02.008
– volume: 28
  start-page: 4600
  year: 2007
  ident: 10.1016/j.ijpharm.2012.04.059_bib0185
  article-title: Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2007.07.029
– volume: 27
  start-page: 14450
  year: 2011
  ident: 10.1016/j.ijpharm.2012.04.059_bib0060
  article-title: Nanofibers resulting from cooperative electrostatic and hydrophobic interactions between peptides and polyelectrolytes of opposite charge
  publication-title: Langmuir
  doi: 10.1021/la202252m
– volume: 8
  start-page: 1799
  year: 2011
  ident: 10.1016/j.ijpharm.2012.04.059_bib0225
  article-title: 18F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography
  publication-title: Mol. Pharm.
  doi: 10.1021/mp2001654
– volume: 4
  start-page: 5321
  year: 2010
  ident: 10.1016/j.ijpharm.2012.04.059_bib0015
  article-title: Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles
  publication-title: ACS Nano
  doi: 10.1021/nn100816s
– volume: 303
  start-page: 1818
  year: 2004
  ident: 10.1016/j.ijpharm.2012.04.059_bib0005
  article-title: Drug delivery systems: entering the mainstream
  publication-title: Science
  doi: 10.1126/science.1095833
– volume: 57
  start-page: 4814
  year: 1972
  ident: 10.1016/j.ijpharm.2012.04.059_bib0115
  article-title: Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.1678153
– volume: 27
  start-page: 312
  year: 2010
  ident: 10.1016/j.ijpharm.2012.04.059_bib0080
  article-title: Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery
  publication-title: Mol. Membr. Biol.
  doi: 10.3109/09687688.2010.522117
– volume: 128
  start-page: 14792
  year: 2006
  ident: 10.1016/j.ijpharm.2012.04.059_bib0235
  article-title: Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja0645943
– year: 2001
  ident: 10.1016/j.ijpharm.2012.04.059_bib0085
– volume: 28
  start-page: 1520
  year: 2011
  ident: 10.1016/j.ijpharm.2012.04.059_bib0190
  article-title: Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-011-0453-2
– volume: 65
  start-page: 177
  year: 1965
  ident: 10.1016/j.ijpharm.2012.04.059_bib0180
  article-title: The isoelectric points of solid oxides, solid hydroxides, and aqueous hydroxo complex systems
  publication-title: Chem. Rev.
  doi: 10.1021/cr60234a002
– volume: 307
  start-page: 93
  year: 2006
  ident: 10.1016/j.ijpharm.2012.04.059_bib0170
  article-title: Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2005.10.010
– volume: 32
  start-page: 2625
  year: 2011
  ident: 10.1016/j.ijpharm.2012.04.059_bib0025
  article-title: Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2010.12.011
– volume: 108
  start-page: 362
  year: 2005
  ident: 10.1016/j.ijpharm.2012.04.059_bib0220
  article-title: Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2005.08.017
– volume: 24
  start-page: 1001
  year: 2003
  ident: 10.1016/j.ijpharm.2012.04.059_bib0255
  article-title: Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating
  publication-title: Biomaterials
  doi: 10.1016/S0142-9612(02)00440-4
– volume: 7
  start-page: 1033
  year: 1995
  ident: 10.1016/j.ijpharm.2012.04.059_bib0040
  article-title: Bioactive silicon structure fabrication through nanoetching techniques
  publication-title: Adv. Mater.
  doi: 10.1002/adma.19950071215
– volume: 29
  start-page: 837
  year: 2012
  ident: 10.1016/j.ijpharm.2012.04.059_bib0125
  article-title: Mesoporous silicon (PSi) for sustained peptide delivery: effect of PSi microparticle surface chemistry on peptide YY3-36 release
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-011-0611-6
– volume: 45
  start-page: 8350
  year: 2006
  ident: 10.1016/j.ijpharm.2012.04.059_bib0160
  article-title: The PP-fold solution structure of human polypeptide YY and human PYY3-36 as determined by NMR
  publication-title: Biochemistry-US
  doi: 10.1021/bi060359l
– volume: 39
  start-page: 477
  year: 2001
  ident: 10.1016/j.ijpharm.2012.04.059_bib0050
  article-title: Structure and folding of glucagon-like peptide-1-(7-36)-amide in aqueous trifluoroethanol studied by NMR spectroscopy
  publication-title: Magn. Reson. Chem.
  doi: 10.1002/mrc.880
– volume: 4
  start-page: 3023
  year: 2010
  ident: 10.1016/j.ijpharm.2012.04.059_bib0030
  article-title: Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats
  publication-title: ACS Nano
  doi: 10.1021/nn901657w
– year: 2001
  ident: 10.1016/j.ijpharm.2012.04.059_bib0035
– year: 2000
  ident: 10.1016/j.ijpharm.2012.04.059_bib0150
– volume: 1
  start-page: 496
  year: 1985
  ident: 10.1016/j.ijpharm.2012.04.059_bib0140
  article-title: Improved techniques for particle size determination by quasi-elastic light scattering
  publication-title: Langmuir
  doi: 10.1021/la00064a016
– volume: 5
  start-page: 1366
  year: 2011
  ident: 10.1016/j.ijpharm.2012.04.059_bib0270
  article-title: Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects
  publication-title: ACS Nano
  doi: 10.1021/nn103077k
– start-page: 1
  year: 2008
  ident: 10.1016/j.ijpharm.2012.04.059_bib0020
  article-title: On the complexity of electrostatic suspension stabilization of functionalized silica nanoparticles for biotargeting and imaging applications
  publication-title: J. Nanomater.
  doi: 10.1155/2008/712514
– volume: 23
  start-page: 4315
  year: 2007
  ident: 10.1016/j.ijpharm.2012.04.059_bib0200
  article-title: On the nature of the Brønsted acidic groups on native and functionalized mesoporous siliceous SBA-15 as studied by benzylamine adsorption from solution
  publication-title: Langmuir
  doi: 10.1021/la062450w
– volume: 6
  start-page: 1219
  year: 2009
  ident: 10.1016/j.ijpharm.2012.04.059_bib0095
  article-title: Recent trends in stabilising peptides and proteins in pharmaceutical formulation – considerations in the choice of excipients
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425240903199143
SSID ssj0006213
Score 2.365867
Snippet Zeta potential of porous silicon nanoparticles is highly dependent on the nature of the loaded peptide and the isotonic medium. Recently, highly promising...
Recently, highly promising results considering the use of porous silicon (PSi) nanoparticles as a controlled and targeted drug delivery system have been...
SourceID proquest
pubmed
crossref
fao
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 230
SubjectTerms Adsorption
Drug Carriers - chemistry
drugs
electrostatic interactions
Gastrointestinal peptide
gastrointestinal system
glucagon-like peptide 1
Glucagon-Like Peptide 1 - chemistry
glucose
isoelectric point
Isotonic formulation
Isotonic Solutions
lactic acid
mannitol
Nanoparticles
Nanoparticles - chemistry
Parenteral peptide delivery
Particle Size
Peptide Fragments - chemistry
Peptide YY - chemistry
peptides
Porosity
Porous silicon
silicon
Silicon - chemistry
sucrose
Zeta potential
Title Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations
URI https://dx.doi.org/10.1016/j.ijpharm.2012.04.059
https://www.ncbi.nlm.nih.gov/pubmed/22569227
https://www.proquest.com/docview/1015466060
https://www.proquest.com/docview/1399904351
https://www.proquest.com/docview/1678561799
Volume 431
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdNetll7LvZR9Fg9FQnsizL0rGUlWxjpdAGchOKZJeEYJvYOWSH7V_fe_5IGGwtDHyx0bMlvaenn-Sn3yPkE7NWSxX7wMIwDITOwgDAURQsMDcVt1ZmHM87f7-W05n4Oo_nR-SyPwuDYZWd7299euOtuyeTrjcn5XI5uWVRk1g-ClHRLJ4PyDGH2V4NyfHFl2_T671DlrzLkgwLJhQ4HOSZrMbLVYkc0RjkxRvSU2Qt_fsUNchs8W8g2kxIV8_I0w5J0ou2ss_JUZq_IGc3LRX17pzeHU5WVef0jN4cSKp3L8mvlraYFhldVkWNBLl0b4bU5p6WGO_iU2p9VWwax0Lh-pHWlpZFjUFG8HUQBwBfbCtaLddgVDnNbQ7r8LZS1G-299Snawz-2FHEx122sOoVmV19vrucBl0yhsCJOK4DxzTLmFWR15l0MkoSloFmAWCohbXwUDkOUMCGKVOpcJozkQI0ih3PXMIBVL4mw7zI0xNCQwVyXsVaCS4ynVjhvIsXTGofeha5ERF9_xvXMZVjwoy16UPSVqZTm0G1GSYMqG1ExnuxsqXqeExA9co1f9icgenkMdETMAZj78ETm9ktx30jhnm8lRyRj72FGBiq-P_F5ikoAl8XCwkrRvZAGQCMmgGGDR8oAwADYG-ioRpvWhPcNxjcs9ScJ2__v23vyBO8ww3sMH5PhvVmm34A5FUvTslg_DM87cbXb5ulLqE
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La-MwEBZteti9lH03-9TC0lPdyLJkW8dStqTbNhSaQG5CkeziEGwTO4fspX-9M7aTsLDbwoJPssaWPKPRJ3n0DSE_mDEqjKXzDAxDT6jU9wAcBd4Mc1NxY8KU43nnm1E4nIhfUzndI-ebszAYVtn5_tanN966Kxl0X3NQZtngjgVNYvnAR0UzOd0nBwKTWvfIwdnl1XC0dcgh77Ikw4IJBXYHeQbz02xeIkc0BnnxhvQUWUv_PkXtp6b4NxBtJqSLV-SwQ5L0rG3sa7KX5G_I8W1LRb0-oePdyarqhB7T2x1J9foteWhpi2mR0qwqaiTIpVszpCZ3tMR4F5dQ46pi2TgWCtfvpDa0LGoMMoK3gzgA-GJV0SpbgFHlNDc5rMPbRlG3XN1Tlyww-GNNER932cKqd2Ry8XN8PvS6ZAyeFVLWnmWKpczEgVNpaMMgilgKmgWAEc-MgcLYcoACxk9YnAirOBMJQCNpeWojDqDyPenlRZ4cEerHIOdiqWLBRaoiI6yzcsZC5XzHAtsnYvP9te2YyjFhxkJvQtLmulObRrVpJjSorU9Ot2JlS9XxnEC8Ua7-w-Y0TCfPiR6BMWhzD55YT-447hsxzOMdh33yfWMhGoYq_n8xeQKKwMdJEcKKkT1RBwCjYoBh_SfqAMAA2BspaMaH1gS3HQb3HCrOo4__37dv5MVwfHOtry9HV5_IS7yDm9m-_Ex69XKVfAEUVs--dqPsEbeeMIc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+isotonic+solutions+and+peptide+adsorption+on+zeta+potential+of+porous+silicon+nanoparticle+drug+delivery+formulations&rft.jtitle=International+journal+of+pharmaceutics&rft.au=Kaasalainen%2C+Martti&rft.au=M%C3%A4kil%C3%A4%2C+Ermei&rft.au=Riikonen%2C+Joakim&rft.au=Kovalainen%2C+Miia&rft.date=2012-07-15&rft.pub=Elsevier+B.V&rft.issn=0378-5173&rft.eissn=1873-3476&rft.volume=431&rft.issue=1-2&rft.spage=230&rft.epage=236&rft_id=info:doi/10.1016%2Fj.ijpharm.2012.04.059&rft.externalDocID=US201500124986
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon